Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy Grant US-11964016-B2 United States of America 23 Apr 2024
Methods for treating or preventing asthma by administering an IL-4R antagonist Grant US-11845800-B2 United States of America 19 Dec 2023
Methods for preventing or treating allergy by administering an IL-4R antagonist Grant US-11771743-B2 United States of America 03 Oct 2023
Methods for treating skin infection by administering an IL-4R antagonist Grant US-11603408-B2 United States of America 14 Mar 2023